European Archives - Page 961 of 982 - European Medical Journal

A Note on Changing Approach to Diagnosis of Alzheimer’s Disease

This short review summarises the conclusions of two different series of studies set out to revise the 1984 National Institute of Neurological and…

Neuropsychiatric Features of Parkinson’s disease with Cognitive Impairment: An Overview

Parkinson’s disease (PD) is known to cause neuropsychiatric symptoms (NPS). It has been established that the more advanced the motor stage of PD is, the…

Motor System Plasticity and Compensation in Multiple Sclerosis

Multiple sclerosis (MS) affects the central nervous system (CNS) by inflammatory lesions, direct axonal injury, and by a rather diffuse and widespread…

EMJ Neurology 2014

I am pleased to introduce to you this second edition of the European Medical Journal Neurology, in which the most important, game-changing…

EMJ

Calls for UK to Pilot New Reimbursement Models for Antibiotics

Pharmaceutical industry leaders are calling for an alternative reimbursement model for antibiotics in the UK sooner rather than later in order to…

EMJ

Drug Shows Promise for Effectively Treating Metabolic Syndrome

University of Utah researchers have discovered that an enzyme involved in intracellular signaling plays a crucial role in developing metabolic syndrome…

Review: Transcatheter Aortic Valve Implantation

Transcatheter aortic valve implantation (TAVI) has evolved as a routine therapeutic option to treat elderly and high-risk patients with symptomatic…

Coronary Stent Evolution – From Pathology to Clinic

Coronary artery disease (CAD) is the leading cause of morbidity and mortality worldwide. The pathogenesis of CAD relates to the presence of…

New Generations of Drug-Eluting Stents – A Brief Review

This review focuses on describing new generations of drug-eluting stents (DES) based on the use of novel stent platforms, coatings, and carrier systems…

Bioresorbable Scaffolds for Cardiovascular Tissue Engineering

Cardiovascular disease is a major cause of morbidity and mortality, especially in developed countries. Currently, when suitable autologous tissue is…